**Core Concept**
Modafinil is a wakefulness-promoting agent used to treat excessive daytime sleepiness associated with narcolepsy, shift work sleep disorder, and obstructive sleep apnea. It acts by increasing the release of neurotransmitters such as dopamine, norepinephrine, and histamine, which regulate the sleep-wake cycle.

**Why the Correct Answer is Right**
Modafinil enhances the activity of dopamine, norepinephrine, and histamine in the brain, which are key neurotransmitters involved in regulating arousal and wakefulness. It binds to the dopamine transporter, inhibiting the reuptake of dopamine and increasing its availability in the synaptic cleft. This leads to increased activity in the brain's wakefulness centers, including the hypothalamus and the brainstem. By modulating the activity of these neurotransmitters, modafinil helps to counteract the excessive daytime sleepiness associated with narcolepsy, shift work sleep disorder, and obstructive sleep apnea.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because modafinil is not primarily used to treat anxiety disorders, although it may have anxiolytic effects as a side effect.
**Option B:** This option is incorrect because modafinil is not primarily used to treat attention deficit hyperactivity disorder (ADHD), although it may be used off-label for this condition.
**Option C:** This option is incorrect because modafinil is not primarily used to treat depression, although it may have mood-elevating effects as a side effect.

**Clinical Pearl / High-Yield Fact**
Modafinil is not a controlled substance, but it can have abuse potential due to its stimulant-like effects. It is also not recommended for patients with a history of psychosis or schizophrenia.

**Correct Answer:** C. Obstructive sleep apnea.